PIK3CA and neoplasm: For patient #17, pre-surgical cfDNA analysis showed GNAQ p.F220L (0.36%) and PIK3CA p.A598 (3.9%) variants while these mutations were not detected in the FFPE tumor sample, and the MAF of the two alterations was 0.1% and 2.32%, respectively (Supplementary Table S6).